Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 31 Projects
Project # Contact PI Funding Organization Fiscal Year
Therapeutic strategies to target Tau-Synaptogyrin-3 interaction
T-PEP-20-677922 Versteken, Patrik Alzheimer's Association|Tau Consortium 2020
Cognitive training to promote brain health: implementation and engagement
GBHI_ALZ-18-544160 Panizzutti, Rogerio Global Brain Health Institute (GBHI)|Alzheimer's Association|Alzheimer's Society 2018
Functional validation of miR-132 loss in AD and therapeutic targeting
AARF-16-442853 Salta, Evgenia Alzheimer's Association 2016
Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)
EUJPND-Belgium-FIE-JANSSEN PHARMACEUTICA-281 JANSSEN PHARMACEUTICA Flanders Innovation & Entrepreneurship 2016
AD Immunotherapy : Towards a disease modification therapy in Alzheimer disease via targeting Tau protein with monoclonal antibodies
EUJPND-Belgium-FIE-JANSSEN PHARMACEUTICA-284 JANSSEN PHARMACEUTICA Flanders Innovation & Entrepreneurship 2016
Therapeutic target identification for FTD/ALS using human induced pluripotent stem cell models (iPSC)
EUJPND-Belgium-FIE-KU Leuven-286 KU Leuven Flanders Innovation & Entrepreneurship 2016
Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)
EUJPND-Belgium-FIE-KU Leuven-288 KU Leuven Flanders Innovation & Entrepreneurship 2016
Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)
EUJPND-Belgium-FIE-KU Leuven-289 KU Leuven Flanders Innovation & Entrepreneurship 2016
VIND : Flemish Impulse Funding for Networks for Dementia Research
EUJPND-Belgium-FIE-Van Broeckhoven-294 Van Broeckhoven, Christine Flanders Innovation & Entrepreneurship 2016
Examining the effects of S1P receptor drugs in Alzheimer’s disease
EUJPND-Ireland-HRB-Dev-817 Dev, Kumlesh K. Health Research Board 2016